Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 144.080
- +1.590+1.12%
Close Feb 14 16:00 ET
- 144.000
- -0.080-0.06%
Pre 05:47 ET
8.62BMarket Cap-21.05P/E (TTM)
146.905High141.822Low551.28KVolume142.850Open142.490Pre Close79.42MTurnover0.93%Turnover RatioLossP/E (Static)59.84MShares161.00052wk High-77.80P/B8.56BFloat Cap111.09052wk Low--Dividend TTM59.40MShs Float183.980Historical High--Div YieldTTM3.57%Amplitude11.920Historical Low144.055Avg Price1Lot Size
Ascendis Pharma A/S News
Ascendis Pharma A/S | SCHEDULE 13G/A: Others
Ascendis Pharma A/S | 20-F: FY2024 Annual Report
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | SCHEDULE 13G/A: Others
Ascendis Pharma A/S | SCHEDULE 13G/A: Others
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.